CN103750480B - 一种解酒功能饮料 - Google Patents
一种解酒功能饮料 Download PDFInfo
- Publication number
- CN103750480B CN103750480B CN201310706645.2A CN201310706645A CN103750480B CN 103750480 B CN103750480 B CN 103750480B CN 201310706645 A CN201310706645 A CN 201310706645A CN 103750480 B CN103750480 B CN 103750480B
- Authority
- CN
- China
- Prior art keywords
- parts
- beverage
- water
- hangover
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 24
- 206010019133 Hangover Diseases 0.000 title claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 238000000855 fermentation Methods 0.000 claims abstract description 19
- 230000004151 fermentation Effects 0.000 claims abstract description 19
- 235000012907 honey Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 241000234435 Lilium Species 0.000 claims abstract description 9
- 244000197580 Poria cocos Species 0.000 claims abstract description 9
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 19
- 244000046146 Pueraria lobata Species 0.000 claims description 15
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 15
- 235000021552 granulated sugar Nutrition 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 238000011049 filling Methods 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 230000003068 static effect Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000010792 warming Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 34
- 230000006870 function Effects 0.000 abstract description 15
- 230000035922 thirst Effects 0.000 abstract description 13
- 239000003814 drug Substances 0.000 abstract description 12
- 238000010791 quenching Methods 0.000 abstract description 9
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 6
- 229930006000 Sucrose Natural products 0.000 abstract description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 5
- 239000005556 hormone Substances 0.000 abstract description 5
- 229940088597 hormone Drugs 0.000 abstract description 5
- 239000011573 trace mineral Substances 0.000 abstract description 5
- 235000013619 trace mineral Nutrition 0.000 abstract description 5
- 229940088594 vitamin Drugs 0.000 abstract description 5
- 239000011782 vitamin Substances 0.000 abstract description 5
- 235000013343 vitamin Nutrition 0.000 abstract description 5
- 229930003231 vitamin Natural products 0.000 abstract description 5
- 235000001014 amino acid Nutrition 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000027939 micturition Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000025254 Cannabis sativa Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 3
- 241001598107 Imperata Species 0.000 abstract 1
- 230000000171 quenching effect Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 20
- 235000009508 confectionery Nutrition 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 235000019640 taste Nutrition 0.000 description 13
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 12
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 206010047700 Vomiting Diseases 0.000 description 8
- 230000008673 vomiting Effects 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 241000219780 Pueraria Species 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 4
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 4
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229960004373 acetylcholine Drugs 0.000 description 4
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 4
- 206010036067 polydipsia Diseases 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 206010057315 Daydreaming Diseases 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000001147 anti-toxic effect Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 235000007240 daidzein Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 230000000971 hippocampal effect Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 108060003345 Adrenergic Receptor Proteins 0.000 description 1
- 102000017910 Adrenergic receptor Human genes 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000004302 Microvascular Angina Diseases 0.000 description 1
- 208000026018 Microvascular coronary artery disease Diseases 0.000 description 1
- SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical compound C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002908 adrenolytic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000002416 angiotensin derivative Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000002763 arrhythmic effect Effects 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000014058 juice drink Nutrition 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000008113 selfheal Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种解酒功能饮料，由下列原料组分按重量份制成：百合18～22、葛根18～22、玉竹14～16、茯苓13～17、鲜白茅根18～22、鲜芦根18～22、白砂糖240～260、蜂蜜120～130、水19000～21000；并公开了制备方法。本发明利用上述中药通过发酵后，消除了中药的毒副作用，提高中药药效，并富含各种维生素和氨基酸及微量元素，利用纯中药原料，无需添加任何激素和化学成分，具有解酒止渴、利尿排毒功能，对人体健康解酒功效显著，本产品的推广利国利民。
Description
技术领域
本发明涉及一种饮料，尤其涉及一种解酒功能饮料。
背景技术
功能饮料是指以水为基本原料，由不同的配方和制造工艺生产出来，供人们直接饮用的液体食品。功能饮料除提供水分外，由于在不同品种的功能饮料中含有不等量的糖、酸、乳以及各种氨基酸、维生素、无机盐等营养成分，因此有一定的营养。功能饮料一般可分为含酒精功能饮料和无酒精功能饮料。无酒精功能饮料是指酒精含量小于0.5％，无酒精功能饮料分为果蔬汁功能饮料类、蛋白功能饮料类、包装饮用水类、茶功能饮料类、咖啡功能饮料类、固体功能饮料类、特殊用途功能饮料类、植物功能饮料类、风味功能饮料类、其它功能饮料类等10类。
现有市场上流行的特殊用途饮料类或植物饮料类(非果蔬类的)，如：“王老吉”植物饮料，食品生产许可证编号：QS510006010359川卫食证字(2008)第510123～00160号，配料：水、白沙糖、仙草、蛋花、布渣叶、菊花、金银花、夏枯草、甘草。“红牛”维生素功能饮料，食品生产许可证编号：QS110006012919(京药)卫食证字(2006)第110000～JS0135号，配料：水、白沙糖、香精、牛磺酸、赖氨酸、肌醇、烟酰胺、维生素B6、维生素B12。
这些饮料均具有自己所提供的功能，而采用纯中药(符合国家饮料使用范围)，无激素和化学成分，具有解酒止渴、利尿排毒功能，健康解酒的功能性饮料还未见报道。
发明内容
为解决上述问题，本发明提供一种纯中药原料，不添加任何激素和化学成分、具有解酒止渴、利尿排毒功能的健康解酒功能饮料。
为达到上述目的，本发明所采用的技术方案是：一种解酒功能饮料，由下列原料组分按重量份制成：百合18～22、葛根18～22、玉竹14～16、茯苓13～17、鲜白茅根18～22、鲜芦根18～22、白砂糖240～260、蜂蜜120～130、水19000～21000。
将上述原料组分制成本发明产品的制备方法是：
(1)将上述原料组分中的中药组分在水中浸泡30～40min后，清洗并去除杂质，放入提篮中，在煮沸的水中，搅拌，提篮上下进水出水重复3～5次，每次时间0.3～0.5min，结束后提篮，送温控室的晾架上降温至8～10℃，静置12h，期间通风，静置结束后升温至25～30℃时保温；
(2)将原料组分中水煮沸后降温至50～60℃，加入原料组分中的白砂糖和蜂蜜，搅拌至完全融化在水中形成的混合液，将步骤一中处理后的中药组分和混合液放入发酵罐中混合，加入混合物总量0.01～0.03％的拜耳结合酵母菌，设定温度29～31℃，湿度控制在27％～29％，静止培养2～5天；
(3)将发酵后的混合物取出过滤，所获得的滤液灌装在容器内即可制成本发明产品。
进一步的，所述水为纯净水。
进一步的，所述灌装容器为玻璃或塑料容器，使用前须严格消毒处理。
进一步的，所述发酵罐所在的发酵室在发酵前必须进行消毒处理。
本发明所采用的中药组分：
百合：性寒、味甘，入心、肺经；功效：养阴润肺，清心安神。用于阴虚久咳，痰中带血，虚烦惊悸，失眠多梦，精神恍惚。
葛根：性甘、辛、平、无毒，主治：消渴、身大热、呕吐、诸弊，起阴气，解诸毒。
玉竹：味甘，性微寒；归肺、胃经；养阴润燥，生津止渴。用于肺胃阴伤，燥热咳嗽，咽干口渴，内热消渴。
鲜白茅根：味甘，性寒。入肺、胃、小肠经；凉血止血，清热解毒。用于吐血，尿血，热淋，水肿，黄疸，小便不利，热病烦渴，胃热呕哕，咳嗽。
茯苓：味甘，性淡平；入心、肺、脾经。具有渗湿利水，健脾和胃，宁心安神的功效。
鲜芦根：味甘，性寒，入肺、胃经；功效：清热生津，除烦，止呕，利尿。用于热病烦渴，胃热呕哕，肺热咳嗽，肺痈吐脓，热淋涩痛。
蜂蜜：味甘，性平；归脾、胃、肺、大肠经。调补脾胃；缓急止痛；润肺止咳；润肠通便；润肤生肌；解毒。蜂蜜中主含葡萄糖，果糖；其他还含蔗糖，糊精，有机酸，蛋白质，挥发油，蜡，花粉粒，维生素B1、B2、B6、C、K、H，淀粉酶，转入酶，过氧化酶，酯酶，生长刺激素，乙酰胆碱，烟酸，泛酸，胡萝卜素，无机元素钙、硫、磷、镁、钾、钠、碘等。
本发明以葛根为君药，百合、玉竹为臣药；茯苓、鲜芦根、鲜白茅根辅佐上药，达到解酒止渴、利尿排毒的功效。蜂蜜在此处起到的作用有三点，一是其药用价值，二是作为发酵能量，三是利用其所含有的微量元素和氨基酸等补充饮料中的成分，而无需添加剂。
本发明的有益效果在于：上述中药通过发酵后，消除了中药的毒副作用，提高中药药效，并富含各种维生素和氨基酸及微量元素，利用纯中药原料，无需添加任何激素和化学成分，具有解酒止渴、利尿排毒功能，对人体健康解酒功效显著，本产品的推广利国利民。
具体实施方式
实施例1
一种解酒功能饮料，其原料组分按重量份：百合18、葛根18、玉竹14、茯苓13、鲜白茅根18、鲜芦根18、白砂糖240、蜂蜜120、水19000。
将上述组分制成本发明产品的制备方法是：
(1)将上述中药组分在水中浸泡30min后，清洗并去除杂质，放入提篮中，在煮沸的水中，搅拌，提篮上下进水出水重复3次，每次时间0.3min，结束后提篮，送温控室的晾架上降温至8℃，静置12h，期间通风，静置结束后升温至25℃时保温；
(2)将组分中水煮沸后降温至50℃，加入白砂糖和蜂蜜，搅拌至完全融化在水中形成的混合液，将步骤一中处理后的中药组分和混合液放入发酵罐中混合，加入混合物总量0.01％的拜耳结合酵母菌，设定温度29℃，湿度控制在27％，静止培养2天；
(3)将发酵后的混合物取出过滤，所获得的滤液灌装在容器内即可制成本发明产品。
所述水为经过处理的纯净水。
所述灌装容器为玻璃或塑料容器，使用前须严格消毒处理。
所述发酵罐所在的发酵室在发酵前必须进行消毒处理。
本发明所采用的中药组分：
百合：性寒、味甘，入心、肺经；功效：养阴润肺，清心安神。用于阴虚久咳，痰中带血，虚烦惊悸，失眠多梦，精神恍惚。
葛根：性甘、辛、平、无毒，主治：消渴、身大热、呕吐、诸弊，起阴气，解诸毒。
玉竹：味甘，性微寒；归肺、胃经；养阴润燥，生津止渴。用于肺胃阴伤，燥热咳嗽，咽干口渴，内热消渴。
鲜白茅根：味甘，性寒。入肺、胃、小肠经；凉血止血，清热解毒。用于吐血，尿血，热淋，水肿，黄疸，小便不利，热病烦渴，胃热呕哕，咳嗽。
茯苓：味甘，性淡平；入心、肺、脾经。具有渗湿利水，健脾和胃，宁心安神的功效。
鲜芦根：味甘，性寒，入肺、胃经；功效：清热生津，除烦，止呕，利尿。用于热病烦渴，胃热呕哕，肺热咳嗽，肺痈吐脓，热淋涩痛。
葛根的作用：
1、对平滑肌的作用，葛根中的大豆甙元具有抗乙酰胆碱作用，能够明显收缩平滑肌，被认为是葛根解痉作用的主要成分。
2、对冠状循环的作用，葛根水煎剂、醇浸膏、总黄酮和葛根素均有明显的扩张冠状血管的作用，能使冠血流量增加，血管阻力降低。
3、对心肌梗塞和心律失常的作用，葛根醇浸膏、大豆甙元和葛根素均有明显的对抗乌头碱和氯化钡诱发的心律失常作用，葛根素还能明显缩短氯彷、肾上腺素诱发的家兔心律失常时间，葛根素能明显缩小心肌梗塞范围，被认为是一种β～肾上腺素受体阻滞剂。
4、对心脏功能和心肌代谢的影响，葛根总黄酮和葛根素能减慢心率，降低心脏总外周阻力，减少心肌耗氧量；提高心肌工作效率.葛根素还能明显减少缺血引起的心肌乳酸的产生，改善梗塞心肌的代谢。
5、对血压和外周血管的作用，葛根总葛酮和葛根素能使血浆肾素活性和血管紧张素显著降低，血压下降.葛根素对微循环障碍有明显的改善作用，主要表现为增加微血管运动的振幅和提高局部微血流量；葛根总黄酮具有明显扩张脑血管的作用，改善脑微循环和外周循环.据报道，葛根素还能改善视网膜血管末稍单位的阻滞状态，从而提高视功能。
6、抑制血小板聚集作用，葛根素能抑制二磷酸腺苷(ADP)诱导和5～HT(5～羟色胺)与ADP联合诱导的人和动物的血小板聚集；另外，葛根素还能明显抑制由凝血酶诱导的血小板中5～HT的释放，具有抗血栓形成作用。
7、降血糖的作用，葛根素能对抗肾上腺素的升血糖作用，具有一定的降血糖能力。
8、对体温的影响，葛根总黄酮对内毒素致体温升高具有转持久而明显的降温作用，临床上常用于外感发热诸症。
9、对记忆的影响，葛根总黄酮和醇提物能提高大鼠大脑皮层和海马乙酰胆碱含量，并降低海马乙酰胆碱转移酶活性，对抗东莨碱所效的大鼠记忆获得性障碍，这说明，葛根具有一定的改善学习记忆的能力。
蜂蜜中主含葡萄糖，果糖；其他还含蔗糖，糊精，有机酸，蛋白质，挥发油，蜡，花粉粒，维生素B1、B2、B6、C、K、H，淀粉酶，转入酶，过氧化酶，酯酶，生长刺激素，乙酰胆碱，烟酸，泛酸，胡萝卜素，无机元素钙、硫、磷、镁、钾、钠、碘等。
本发明对上述组方的中药进行发酵，利用上述组方富含的各种氨基酸、微量元素等，无需单独添加化学成分，并考虑到饮料的口感选择组方，所生产饮料酸甜可口，符合饮酒后人的口味，解酒止渴、利尿排毒，具有健康解酒的功效。
实施例2
一种解酒功能饮料，其原料组分按重量份：百合22、葛根22、玉竹16、茯苓17、鲜白茅根22、鲜芦根22、白砂糖260、蜂蜜130、水21000。将上述中药组分在水中浸泡40min后，清洗并去除杂质，放入提篮中，在煮沸的水中，搅拌，提篮上下进水出水重复5次，每次时间0.5min，结束后提篮，送温控室的晾架上降温至10℃，静置12h，期间通风，静置结束后升温至30℃时保温；
将组分中水煮沸后降温至60℃，加入白砂糖和蜂蜜，搅拌至完全融化在水中形成的混合液，将上步中处理后的中药组分和混合液放入发酵罐混合，加入混合物总量0.03％的拜耳结合酵母菌，设定温度31℃，湿度控制在29％，静止培养5天；
将发酵后的混合物取出过滤，所获得的滤液灌装在容器内即可制成本发明产品。
实施例3
一种解酒功能饮料，其原料组分按重量份：百合20、葛根20、玉竹15、茯苓15、鲜白茅根20、鲜芦根20、白砂糖250、蜂蜜125、水20000。将上述中药组分在水中浸泡35min后，清洗并去除杂质，放入提篮中，在煮沸的水中，搅拌，提篮上下进水出水重复4次，每次时间0.4min，结束后提篮，送温控室的晾架上降温至9℃，静置12h，期间通风，静置结束后升温至28℃时保温；
将组分中水煮沸后降温至55℃，加入白砂糖和蜂蜜，搅拌至完全融化在水中形成的混合液，将上步中处理后的中药组分和混合液放入发酵罐混合，加入混合物总量0.02％的拜耳结合酵母菌，设定温度30℃，湿度控制在28％，静止培养4天；
将发酵后的混合物取出过滤，所获得的滤液灌装在容器内即可制成本发明产品。
以上实施例中，最佳实施例是实施例3。
本发明产品存在菌丝属于正常，适合保存温度为0～10℃，常温下放置亦不会变质，但当温度高于30℃时须放入低温保存；本发明产品开瓶即可饮用，味道甜酸适宜，符合饮酒人员的口感，由于利用中药发酵，消除了中药的毒副作用，提高中药药效，并富含各种维生素和氨基酸及微量元素，将纯中药为原料，无需添加任何激素和化学成分，解酒止渴、利尿排毒，具有健康解酒的功效，符合我国人民的健康需要，利国利民。
以上实施例的说明只用于理解本发明的原理，不理解为对本发明的限制。
Claims (4)
1.一种解酒功能饮料，其特征在于，由下列原料组分按重量份制成：百合18～22、葛根18～22、玉竹14～16、茯苓13～17、鲜白茅根18～22、鲜芦根18～22、白砂糖240～260、蜂蜜120～130、水19000～21000；制备方法是：
(1)将上述原料组分中的中药组分在水中浸泡30～40min后，清洗并去除杂质，放入提篮中，在煮沸的水中，搅拌，提篮上下进水出水重复3～5次，每次时间0.3～0.5min，结束后提篮，送温控室的晾架上降温至8～10℃，静置12h，期间通风，静置结束后升温至25～30℃时保温；
(2)将原料组分中水煮沸后降温至50-60℃，加入原料组分中的白砂糖和蜂蜜，搅拌至完全融化在水中形成混合液，将步骤一中处理后的中药组分和混合液放入发酵罐中混合，加入混合物总量0.01-0.03％的拜耳结合酵母菌，设定温度29～31℃，湿度控制在27％～29％，静止培养2-5天；
(3)将发酵后的混合物取出过滤，所获得的滤液灌装在容器内即可制成产品。
2.根据权利要求1所述的解酒功能饮料，其特征在于：所述水为纯净水。
3.根据权利要求1所述的解酒功能饮料，其特征在于：所述灌装容器为玻璃或塑料容器，使用前须严格消毒处理。
4.根据权利要求1所述的解酒功能饮料，其特征在于：所述发酵罐所在的发酵室在发酵前必须进行消毒处理。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310706645.2A CN103750480B (zh) | 2013-12-09 | 2013-12-09 | 一种解酒功能饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310706645.2A CN103750480B (zh) | 2013-12-09 | 2013-12-09 | 一种解酒功能饮料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103750480A CN103750480A (zh) | 2014-04-30 |
| CN103750480B true CN103750480B (zh) | 2015-03-11 |
Family
ID=50517933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310706645.2A Active CN103750480B (zh) | 2013-12-09 | 2013-12-09 | 一种解酒功能饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103750480B (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104256625B (zh) * | 2014-10-23 | 2016-03-02 | 甘林林 | 一种解酒酵素及其生产工艺 |
| CN104771567A (zh) * | 2015-03-31 | 2015-07-15 | 周冠旻 | 一种解酒药物组合物 |
| CN104872772A (zh) * | 2015-06-14 | 2015-09-02 | 杜圣艳 | 一种防治湿疹的功能饮料 |
| CN104872761A (zh) * | 2015-06-14 | 2015-09-02 | 杜圣艳 | 一种防治风湿功能饮料 |
| CN104872774A (zh) * | 2015-06-14 | 2015-09-02 | 杜沛雨 | 一种防治便秘的功能饮料 |
| CN104856046A (zh) * | 2015-06-14 | 2015-08-26 | 杜圣艳 | 一种降血糖功能饮料 |
| CN107410798A (zh) * | 2017-05-09 | 2017-12-01 | 天津岂均生物科技有限公司 | 一种具有提高免疫力功效的中药发酵饮料及其制备方法 |
| CN109170435A (zh) * | 2018-09-28 | 2019-01-11 | 潜山梦想葛业专业合作社 | 一种清热解渴葛根饮料及其制备方法 |
| CN109453316A (zh) * | 2018-12-28 | 2019-03-12 | 山东大学 | 一种用于解酒的饮料配方及其制作方法 |
| TWI700363B (zh) * | 2019-01-25 | 2020-08-01 | 大江生醫股份有限公司 | 植物發酵物及其用於肺部保健及抗氧化的用途 |
| CN109717437A (zh) * | 2019-01-27 | 2019-05-07 | 山西智圆行方健康管理咨询有限公司 | 一种解酒复合蜂蜜膏及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1371732A (zh) * | 2002-02-28 | 2002-10-02 | 傅强 | 一种解酒饮料 |
| CN1299738C (zh) * | 2004-06-02 | 2007-02-14 | 许金宇 | 一种用中草药制成的解酒饮料及其制造方法 |
-
2013
- 2013-12-09 CN CN201310706645.2A patent/CN103750480B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN103750480A (zh) | 2014-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103750480B (zh) | 一种解酒功能饮料 | |
| CN103704837B (zh) | 一种健胃功能饮料 | |
| CN103999909A (zh) | 一种保健蛋糕及其制备方法 | |
| CN101919553A (zh) | 刺梨果味饮料 | |
| CN102283408A (zh) | 一种丝瓜伤流液功能饮料及其制备方法 | |
| CN104997087A (zh) | 一种补气血功能饮料 | |
| CN101978892B (zh) | 一种竹醋解酒饮料及其制备方法 | |
| CN102599301B (zh) | 一种三泡台复合茶饮料 | |
| CN106106917A (zh) | 紫五加酵素茶及其制备方法 | |
| CN103549598A (zh) | 雪菊免疫功能饮料的制备方法 | |
| CN103750478B (zh) | 一种前列康功能饮料 | |
| CN107373250A (zh) | 一种银杏叶乳酸菌保健饮料及其制备方法 | |
| CN104643201A (zh) | 解酒饮料 | |
| CN103461596A (zh) | 雪菊茶饮料的制备方法 | |
| CN103725467A (zh) | 一种高丽参红葡萄酒的制备方法 | |
| CN104997115A (zh) | 一种降血压功能饮料 | |
| CN104544405A (zh) | 一种荔枝味改善宇航员睡眠质量功能饮料及其制备方法 | |
| CN103750479B (zh) | 一种妇乐功能饮料 | |
| CN104872773A (zh) | 一种防治感咳功能饮料 | |
| CN102835700A (zh) | 具有润肺、养胃功效的保健饮料及其制作方法 | |
| CN108125081A (zh) | 一种百香果甜香型果蔬饮料以及制备工艺 | |
| CN107969696A (zh) | 一种柚子醒酒膏 | |
| CN107669811A (zh) | 一种具有咖啡口味的保健中药及其制备方法 | |
| CN102860378A (zh) | 一种降压保健柿子醋茶饮料及其制备方法 | |
| CN102845577A (zh) | 野生甜茶叶和野生葛根处复方制成的灵茶 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150923 Address after: 235000 Anhui Province, Huaibei City Xiangshan District phase Road No. 37 Building 2 unit 5 Room 303 Patentee after: Du Shengyan Address before: 235000 Lantau Peak Province Economic Development Zone, Anhui, Feng Feng Road, No. 12, No. Patentee before: Anhui Shengzhitang Biological Science & Technology Co., Ltd. |
|
| DD01 | Delivery of document by public notice |
Addressee: Du Shengyan Document name: Notification of Passing Examination on Formalities |
|
| DD01 | Delivery of document by public notice |
Addressee: Du Shengyan Document name: Notification to Pay the Fees |
|
| DD01 | Delivery of document by public notice |
Addressee: Du Shengyan Document name: Notification of Termination of Patent Right |
|
| DD01 | Delivery of document by public notice |
Addressee: Du Shengyan Document name: Notification of Decision on Request for Restoration of Right |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20201013 Address after: 235000 discovery tour of Changshan South Road, Xiangshan District, Huaibei City, Anhui Province 2 1016 Patentee after: Anhui kangjitang Health Technology Co., Ltd Address before: 235000 Anhui Province, Huaibei City Xiangshan District phase Road No. 37 Building 2 unit 5 Room 303 Patentee before: Du Shengyan |
|
| TR01 | Transfer of patent right | ||
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Du Shengyan Document name: Notice of conformity |